149 related articles for article (PubMed ID: 20677643)
21. Reduced expression of the Tslc1 gene and its aberrant DNA methylation in rat lung tumors.
Shimizu K; Itsuzaki Y; Onishi M; Fujii H; Honoki K; Tsujiuchi T
Biochem Biophys Res Commun; 2006 Aug; 347(1):358-62. PubMed ID: 16814249
[TBL] [Abstract][Full Text] [Related]
22. [Expressions and clinical significances of TSLC1 and 4.1B in non-small cell lung cancer].
Wang Z; Yang K; Wang X; Zhang J; Hao D; Chen Z
Zhongguo Fei Ai Za Zhi; 2010 Nov; 13(11):1041-5. PubMed ID: 21081044
[TBL] [Abstract][Full Text] [Related]
23. The minimal Tumor Suppressor in Lung Cancer-1 promoter is restrained by an inhibitory region.
Hori RT
Mol Biol Rep; 2010 Apr; 37(4):1979-85. PubMed ID: 19653122
[TBL] [Abstract][Full Text] [Related]
24. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer.
Kuramochi M; Fukuhara H; Nobukuni T; Kanbe T; Maruyama T; Ghosh HP; Pletcher M; Isomura M; Onizuka M; Kitamura T; Sekiya T; Reeves RH; Murakami Y
Nat Genet; 2001 Apr; 27(4):427-30. PubMed ID: 11279526
[TBL] [Abstract][Full Text] [Related]
25. Analysis of 11q21-24 loss of heterozygosity candidate target genes in breast cancer: indications of TSLC1 promoter hypermethylation.
Allinen M; Peri L; Kujala S; Lahti-Domenici J; Outila K; Karppinen SM; Launonen V; Winqvist R
Genes Chromosomes Cancer; 2002 Aug; 34(4):384-9. PubMed ID: 12112527
[TBL] [Abstract][Full Text] [Related]
26. The relationship between methylation of the Syk gene in the promoter region and the genesis of lung cancer.
Ma L; Dong S; Zhang P; Xu N; Yan H; Liu H; Li Y; Zhou Q
Clin Lab; 2010; 56(9-10):407-16. PubMed ID: 21086786
[TBL] [Abstract][Full Text] [Related]
27. Involvement of TSLC1 in progression of esophageal squamous cell carcinoma.
Ito T; Shimada Y; Hashimoto Y; Kaganoi J; Kan T; Watanabe G; Murakami Y; Imamura M
Cancer Res; 2003 Oct; 63(19):6320-6. PubMed ID: 14559819
[TBL] [Abstract][Full Text] [Related]
28. [Significance of TSLC1 gene methylation and TSLC1 protein expression in the progression of cervical lesions].
Zhao X; Cui Y; Li Y; Liang S; Zhang Y; Xie L; Xia Z; Du J; Wei L; Li Y
Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):356-60. PubMed ID: 26463026
[TBL] [Abstract][Full Text] [Related]
29. Hypermethylation of the p16 (Ink4a) promoter in B6C3F1 mouse primary lung adenocarcinomas and mouse lung cell lines.
Patel AC; Anna CH; Foley JF; Stockton PS; Tyson FL; Barrett JC; Devereux TR
Carcinogenesis; 2000 Sep; 21(9):1691-700. PubMed ID: 10964101
[TBL] [Abstract][Full Text] [Related]
30. Fine mapping of the 11q22-23 tumor suppressive region and involvement of TSLC1 in nasopharyngeal carcinoma.
Lung HL; Cheng Y; Kumaran MK; Liu ET; Murakami Y; Chan CY; Yau WL; Ko JM; Stanbridge EJ; Lung ML
Int J Cancer; 2004 Nov; 112(4):628-35. PubMed ID: 15382043
[TBL] [Abstract][Full Text] [Related]
31. LHX6 acts as a novel potential tumour suppressor with epigenetic inactivation in lung cancer.
Liu WB; Jiang X; Han F; Li YH; Chen HQ; Liu Y; Cao J; Liu JY
Cell Death Dis; 2013 Oct; 4(10):e882. PubMed ID: 24157876
[TBL] [Abstract][Full Text] [Related]
32. Frequent hypermethylation of RASSF1A and TSLC1, and high viral load of Epstein-Barr Virus DNA in nasopharyngeal carcinoma and matched tumor-adjacent tissues.
Zhou L; Jiang W; Ren C; Yin Z; Feng X; Liu W; Tao Q; Yao K
Neoplasia; 2005 Sep; 7(9):809-15. PubMed ID: 16229803
[TBL] [Abstract][Full Text] [Related]
33. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
Meng CF; Zhu XJ; Peng G; Dai DQ
Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243
[TBL] [Abstract][Full Text] [Related]
34. Involvement of a cell adhesion molecule, TSLC1/IGSF4, in human oncogenesis.
Murakami Y
Cancer Sci; 2005 Sep; 96(9):543-52. PubMed ID: 16128739
[TBL] [Abstract][Full Text] [Related]
35. Dissecting epigenetic silencing complexity in the mouse lung cancer suppressor gene Cadm1.
Reamon-Buettner SM; Borlak J
PLoS One; 2012; 7(6):e38531. PubMed ID: 22701659
[TBL] [Abstract][Full Text] [Related]
36. RA175, which is the mouse ortholog of TSLC1, a tumor suppressor gene in human lung cancer, is a cell adhesion molecule.
Fujita E; Soyama A; Momoi T
Exp Cell Res; 2003 Jul; 287(1):57-66. PubMed ID: 12799182
[TBL] [Abstract][Full Text] [Related]
37. CDX2 serves as a Wnt signaling inhibitor and is frequently methylated in lung cancer.
Liu X; Zhang X; Zhan Q; Brock MV; Herman JG; Guo M
Cancer Biol Ther; 2012 Oct; 13(12):1152-7. PubMed ID: 22892849
[TBL] [Abstract][Full Text] [Related]
38. The cytoplasmic domain is critical to the tumor suppressor activity of TSLC1 in non-small cell lung cancer.
Mao X; Seidlitz E; Ghosh K; Murakami Y; Ghosh HP
Cancer Res; 2003 Nov; 63(22):7979-85. PubMed ID: 14633730
[TBL] [Abstract][Full Text] [Related]
39. Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma.
He Y; Wang Y; Li P; Zhu S; Wang J; Zhang S
Dig Dis Sci; 2011 Mar; 56(3):681-8. PubMed ID: 20725785
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
